Sarah Romano is Chief Financial Officer of KIORA PHARMACEUTICALS INC. Currently has a direct ownership of 22,746 shares of KPRX, which is worth approximately $84,842. The most recent transaction as insider was on Feb 10, 2022, when has been sold 108 shares (Common Stock) at a price of $0.69 per share, resulting in proceeds of $75. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 22.7K
0% 3M change
0% 12M change
Total Value Held $84,842

Sarah Romano Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 10 2022
SELL
Payment of exercise price or tax liability
$75 $0.69 p/Share
108 Reduced 0.47%
22,746 Common Stock
Jan 05 2022
SELL
Payment of exercise price or tax liability
$123 $1.08 p/Share
114 Reduced 0.5%
22,854 Common Stock
Dec 07 2021
SELL
Payment of exercise price or tax liability
$118 $1.3 p/Share
91 Reduced 0.39%
22,968 Common Stock
Nov 02 2021
SELL
Payment of exercise price or tax liability
$164 $1.98 p/Share
83 Reduced 0.36%
23,059 Common Stock
Oct 04 2021
SELL
Payment of exercise price or tax liability
$167 $2.01 p/Share
83 Reduced 0.36%
23,142 Common Stock
Sep 02 2021
SELL
Payment of exercise price or tax liability
$152 $1.81 p/Share
84 Reduced 0.36%
23,225 Common Stock
Aug 03 2021
SELL
Payment of exercise price or tax liability
$209 $2.4 p/Share
87 Reduced 0.37%
23,309 Common Stock
Jul 02 2021
SELL
Payment of exercise price or tax liability
$666 $3.7 p/Share
180 Reduced 0.76%
23,396 Common Stock
Jun 04 2021
SELL
Payment of exercise price or tax liability
$754 $4.19 p/Share
180 Reduced 0.76%
23,576 Common Stock
May 04 2021
SELL
Payment of exercise price or tax liability
$731 $4.13 p/Share
177 Reduced 0.74%
23,756 Common Stock
Apr 08 2021
SELL
Payment of exercise price or tax liability
$889 $4.94 p/Share
180 Reduced 0.75%
23,933 Common Stock
Mar 03 2021
SELL
Payment of exercise price or tax liability
$1,190 $5.46 p/Share
218 Reduced 0.9%
24,113 Common Stock
Feb 02 2021
SELL
Payment of exercise price or tax liability
$8,128 $6.34 p/Share
1,282 Reduced 5.01%
24,331 Common Stock
Jan 04 2021
SELL
Payment of exercise price or tax liability
$558 $4.85 p/Share
115 Reduced 0.45%
25,613 Common Stock
Dec 07 2020
SELL
Payment of exercise price or tax liability
$342 $3.76 p/Share
91 Reduced 0.35%
25,728 Common Stock
Nov 02 2020
SELL
Payment of exercise price or tax liability
$340 $3.51 p/Share
97 Reduced 0.37%
25,819 Common Stock
Oct 02 2020
SELL
Payment of exercise price or tax liability
$380 $3.88 p/Share
98 Reduced 0.38%
25,916 Common Stock

Also insider at

FWBI
First Wave BioPharma, Inc. Healthcare
SR

Sarah Romano

Chief Financial Officer
Waltham, MA

Track Institutional and Insider Activities on KPRX

Follow KIORA PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KPRX shares.

Notify only if

Insider Trading

Get notified when an Kiora Pharmaceuticals Inc insider buys or sells KPRX shares.

Notify only if

News

Receive news related to KIORA PHARMACEUTICALS INC

Track Activities on KPRX